I actually thought they were a bit shaky on explaining the slow take-up of trial participants in the US. Last time it was storms, this time: ‘the market/environment is different...’.
Hanging out for the promised update on clinical outcomes later this month. Along with published articles/presentations that should increase confidence that CE Mark will be granted without further delay in May/June.
Will be interesting to see plans for capital raise also...
1ST USA PATIENT DUE SOON, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $137.7K | 11.46M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1719369 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3242606 | 5 |
View Market Depth
| Last trade - 15.10pm 18/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |